Literature DB >> 27956698

Blockade of Metallothioneins 1 and 2 Increases Skeletal Muscle Mass and Strength.

Serge Summermatter1, Anais Bouzan1, Eliane Pierrel1, Stefan Melly1, Daniela Stauffer1, Sabine Gutzwiller1, Erin Nolin2, Christina Dornelas2, Christy Fryer2, Juliet Leighton-Davies1, David J Glass3, Brigitte Fournier4.   

Abstract

Metallothioneins are proteins that are involved in intracellular zinc storage and transport. Their expression levels have been reported to be elevated in several settings of skeletal muscle atrophy. We therefore investigated the effect of metallothionein blockade on skeletal muscle anabolism in vitro and in vivo We found that concomitant abrogation of metallothioneins 1 and 2 results in activation of the Akt pathway and increases in myotube size, in type IIb fiber hypertrophy, and ultimately in muscle strength. Importantly, the beneficial effects of metallothionein blockade on muscle mass and function was also observed in the setting of glucocorticoid addition, which is a strong atrophy-inducing stimulus. Given the blockade of atrophy and the preservation of strength in atrophy-inducing settings, these results suggest that blockade of metallothioneins 1 and 2 constitutes a promising approach for the treatment of conditions which result in muscle atrophy.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  muscle metabolism

Mesh:

Substances:

Year:  2017        PMID: 27956698      PMCID: PMC5311239          DOI: 10.1128/MCB.00305-16

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

1.  Zinc signalling and subcellular distribution: emerging targets in type 2 diabetes.

Authors:  Eugenio Mocchegiani; Robertina Giacconi; Marco Malavolta
Journal:  Trends Mol Med       Date:  2008-09-04       Impact factor: 11.951

2.  Determination of standard zinc values in the intact tissues of mice by ICP spectrometry.

Authors:  D Verbanac; C Milin; R Domitrović; J Giacometti; R Pantović; Z Ciganj
Journal:  Biol Trace Elem Res       Date:  1997-04       Impact factor: 3.738

Review 3.  Metallothioneins and zinc in cancer diagnosis and therapy.

Authors:  Sona Krizkova; Marketa Ryvolova; Jan Hrabeta; Vojtech Adam; Marie Stiborova; Tomas Eckschlager; Rene Kizek
Journal:  Drug Metab Rev       Date:  2012-10-11       Impact factor: 4.518

Review 4.  Mammalian metallothioneins: properties and functions.

Authors:  Petr Babula; Michal Masarik; Vojtech Adam; Tomas Eckschlager; Marie Stiborova; Libuse Trnkova; Helena Skutkova; Ivo Provaznik; Jaromir Hubalek; Rene Kizek
Journal:  Metallomics       Date:  2012-07-13       Impact factor: 4.526

5.  Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle.

Authors:  Curtis J Wray; Joshua M V Mammen; Dan D Hershko; Per-Olof Hasselgren
Journal:  Int J Biochem Cell Biol       Date:  2003-05       Impact factor: 5.085

6.  Zinc stimulates the activity of the insulin- and nutrient-regulated protein kinase mTOR.

Authors:  C J Lynch; B J Patson; S A Goodman; D Trapolsi; S R Kimball
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-07       Impact factor: 4.310

7.  Redox and zinc signalling pathways converging on protein tyrosine phosphatases.

Authors:  Elisa Bellomo; Christer Hogstrand; Wolfgang Maret
Journal:  Free Radic Biol Med       Date:  2014-12-10       Impact factor: 7.376

Review 8.  The involvement of metallothioneins in mitochondrial function and disease.

Authors:  J Z Lindeque; O Levanets; R Louw; F H van der Westhuizen
Journal:  Curr Protein Pept Sci       Date:  2010-06       Impact factor: 3.272

9.  Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway.

Authors:  Esther Latres; Ami R Amini; Ashley A Amini; Jennifer Griffiths; Francis J Martin; Yi Wei; Hsin Chieh Lin; George D Yancopoulos; David J Glass
Journal:  J Biol Chem       Date:  2004-11-17       Impact factor: 5.157

10.  Zinc is a novel intracellular second messenger.

Authors:  Satoru Yamasaki; Kumiko Sakata-Sogawa; Aiko Hasegawa; Tomoyuki Suzuki; Koki Kabu; Emi Sato; Tomohiro Kurosaki; Susumu Yamashita; Makio Tokunaga; Keigo Nishida; Toshio Hirano
Journal:  J Cell Biol       Date:  2007-05-14       Impact factor: 10.539

View more
  24 in total

1.  Pharmacological Dual Inhibition of Tumor and Tumor-Induced Functional Limitations in a Transgenic Model of Breast Cancer.

Authors:  Ruizhong Wang; Poornima Bhat-Nakshatri; Maria B Padua; Mayuri S Prasad; Manjushree Anjanappa; Max Jacobson; Courtney Finnearty; Victoria Sefcsik; Kyle McElyea; Rachael Redmond; George Sandusky; Narsimha Penthala; Peter A Crooks; Jianguo Liu; Teresa Zimmers; Harikrishna Nakshatri
Journal:  Mol Cancer Ther       Date:  2017-10-04       Impact factor: 6.261

2.  Transcriptome profiling of insulin sensitive tissues from GH deficient mice following GH treatment.

Authors:  Darlene E Berryman; Edward O List; Jonathan A Young; Mat Buchman; Silvana Duran-Ortiz; Colin Kruse; Stephen Bell; John J Kopchick
Journal:  Pituitary       Date:  2021-01-12       Impact factor: 3.599

3.  Metallothioneins regulate the adipogenic differentiation of 3T3-L1 cells via the insulin signaling pathway.

Authors:  Yoshito Kadota; Yuriko Toriuchi; Yuka Aki; Yuto Mizuno; Takashige Kawakami; Tomoko Nakaya; Masao Sato; Shinya Suzuki
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

4.  Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle.

Authors:  Gang Wang; Anup K Biswas; Wanchao Ma; Manoj Kandpal; Courtney Coker; Paul M Grandgenett; Michael A Hollingsworth; Rinku Jain; Kurenai Tanji; Sara Lόpez-Pintado; Alain Borczuk; Doreen Hebert; Supak Jenkitkasemwong; Shintaro Hojyo; Ramana V Davuluri; Mitchell D Knutson; Toshiyuki Fukada; Swarnali Acharyya
Journal:  Nat Med       Date:  2018-06-06       Impact factor: 53.440

Review 5.  Zinc at the crossroads of exercise and proteostasis.

Authors:  Juan Diego Hernández-Camacho; Cristina Vicente-García; Douglas S Parsons; Ignacio Navas-Enamorado
Journal:  Redox Biol       Date:  2020-04-01       Impact factor: 11.799

6.  The neuromuscular junction is a focal point of mTORC1 signaling in sarcopenia.

Authors:  Daniel J Ham; Anastasiya Börsch; Shuo Lin; Marco Thürkauf; Martin Weihrauch; Judith R Reinhard; Julien Delezie; Fabienne Battilana; Xueyong Wang; Marco S Kaiser; Maitea Guridi; Michael Sinnreich; Mark M Rich; Nitish Mittal; Lionel A Tintignac; Christoph Handschin; Mihaela Zavolan; Markus A Rüegg
Journal:  Nat Commun       Date:  2020-09-09       Impact factor: 14.919

Review 7.  Signaling Pathways That Control Muscle Mass.

Authors:  Anna Vainshtein; Marco Sandri
Journal:  Int J Mol Sci       Date:  2020-07-04       Impact factor: 5.923

8.  Hypothalamic-pituitary-adrenal axis activation and glucocorticoid-responsive gene expression in skeletal muscle and liver of Apc mice.

Authors:  Agnès Martin; Josiane Castells; Valentine Allibert; Andréa Emerit; Cindy Zolotoff; Victoire Cardot-Ruffino; Yann S Gallot; Barbara Vernus; Véronique Chauvet; Laurent Bartholin; Laurent Schaeffer; Anne-Cécile Durieux; Christophe Hourdé; François B Favier; Laetitia Mazelin; Damien Freyssenet
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-03-11       Impact factor: 12.063

Review 9.  Role of Zinc Homeostasis in the Pathogenesis of Diabetes and Obesity.

Authors:  Ayako Fukunaka; Yoshio Fujitani
Journal:  Int J Mol Sci       Date:  2018-02-06       Impact factor: 5.923

10.  MicroRNA-mRNA Co-sequencing Identifies Transcriptional and Post-transcriptional Regulatory Networks Underlying Muscle Wasting in Cancer Cachexia.

Authors:  Geysson Javier Fernandez; Juarez Henrique Ferreira; Ivan José Vechetti; Leonardo Nazario de Moraes; Sarah Santiloni Cury; Paula Paccielli Freire; Jayson Gutiérrez; Renato Ferretti; Maeli Dal-Pai-Silva; Silvia Regina Rogatto; Robson Francisco Carvalho
Journal:  Front Genet       Date:  2020-05-29       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.